Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
The Lancet. Infectious Diseases
|
May 24, 2011
Rationale for pertussis booster vaccination throughout life in Europe
Fred Zepp, Ulrich Heininger, Jussi Mertsola, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
November 6, 2016
Cornelius Remschmidt, Thomas Harder, Ole Wichmann, et al.
European Journal of Pediatrics
|
June 15, 2007
Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children
Josef A I Weigl, Wolfram Puppe, Claudius U Meyer, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 13, 2016
MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells
Anette Pietrzak-Nguyen, Keti Piradashvili, Michael Fichter, et al.
The Journal of Pediatrics
|
April 16, 2008
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants
Markus Knuf, Heinz-Joesf Schmitt, Joanne Wolter, et al.
Archives of Toxicology
|
April 1, 2020
Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response
Klaus Abraham, Hans Mielke, Hermann Fromme, et al.
The Journal of Pediatrics
|
March 23, 2010
Booster vaccination after neonatal priming with acellular pertussis vaccine
Markus Knuf, Heinz-Josef Schmitt, Jeanne-Marie Jacquet, et al.
European Journal of Pediatrics
|
June 2, 2007
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months
Fred Zepp, Ulrich Behre, Klaus Kindler, et al.
Acta Ophthalmologica
|
March 17, 2022
Refractive error, accommodation and lens opacification in adults born preterm and full-term: Results from the Gutenberg Prematurity Eye Study (GPES)
Achim Fieß, Agnes Fauer, Eva Mildenberger, et al.
Clinical and Vaccine Immunology : CVI
|
February 3, 2007
Cellular immunity in adolescents and adults following acellular pertussis vaccine administration
Claudius U Meyer, Fred Zepp, Michael Decker, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
The Lancet. Infectious Diseases
|
May 24, 2011
Rationale for pertussis booster vaccination throughout life in Europe
Fred Zepp, Ulrich Heininger, Jussi Mertsola, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
November 6, 2016
Cornelius Remschmidt, Thomas Harder, Ole Wichmann, et al.
European Journal of Pediatrics
|
June 15, 2007
Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children
Josef A I Weigl, Wolfram Puppe, Claudius U Meyer, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 13, 2016
MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells
Anette Pietrzak-Nguyen, Keti Piradashvili, Michael Fichter, et al.
The Journal of Pediatrics
|
April 16, 2008
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants
Markus Knuf, Heinz-Joesf Schmitt, Joanne Wolter, et al.
Archives of Toxicology
|
April 1, 2020
Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response
Klaus Abraham, Hans Mielke, Hermann Fromme, et al.
The Journal of Pediatrics
|
March 23, 2010
Booster vaccination after neonatal priming with acellular pertussis vaccine
Markus Knuf, Heinz-Josef Schmitt, Jeanne-Marie Jacquet, et al.
European Journal of Pediatrics
|
June 2, 2007
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months
Fred Zepp, Ulrich Behre, Klaus Kindler, et al.
Acta Ophthalmologica
|
March 17, 2022
Refractive error, accommodation and lens opacification in adults born preterm and full-term: Results from the Gutenberg Prematurity Eye Study (GPES)
Achim Fieß, Agnes Fauer, Eva Mildenberger, et al.
Clinical and Vaccine Immunology : CVI
|
February 3, 2007
Cellular immunity in adolescents and adults following acellular pertussis vaccine administration
Claudius U Meyer, Fred Zepp, Michael Decker, et al.
Page
of 11